Codrituzumab
Codrituzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Codrituzumab is under investigation in clinical trial NCT01507168 (A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular Carcinoma).
| Trade Name | Codrituzumab |
| Generic | Codrituzumab |
| Codrituzumab Other Names | Codrituzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Codrituzumab
